je.st
news
Zalicus and Epirus complete merger, announce reverse stock split
2014-07-16 06:17:25| Biotech - Topix.net
Zalicus, a 14-year-old biotech firm that had most recently been trying to develop non-addictive painkillers, has ceased to exist after completing its merger with Boston-based Epirus and announcing a 10-for-1 reverse stock split.
Tags: complete
stock
split
reverse
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||